Market News & Trends
Technological Breakthroughs Aiding the Biologics Market
BCC Research reveals in its new report on biologic therapeutic drugs, the biologics or biopharmaceutical therapeutic market holds important implications for the future of medicine…
HER2-Negative Breast Cancer Treatment Market Value to Reach $6.12 Billion
The market value for HER2-negative breast cancer therapeutics will increase more than fourfold, from $1.45 billion in 2013 to an estimated $6.12 billion by 2023,…
Sanofi & MannKind Announce Afrezza, the Only Inhaled Insulin, Now Available in the US
Sanofi and MannKind Corporation announced today that Afrezza® (insulin human) Inhalation Powder, the only inhaled insulin, is now available by prescription in U.S. retail pharmacies…
Pluristem Announces Significant New Findings From Muscle Injury Trial
Pluristem Therapeutics Inc. recently announced an important new finding from its Phase I/II clinical trial of PLacental eXpanded (PLX-PAD) cells in the treatment of muscle…
Lysosomal Therapeutics Raises $20 Million
Lysosomal Therapeutics Inc. recently announced it has raised $20 million in Series A financing. This internal round consisted of expanded funding commitments from its existing…
Breakthrough Brings 3M One Step Closer to Introducing New Alternative Drug Delivery Method
Getting an injection at the doctor’s office typically does not rank high on many people’s wish list. Due to 3M scientists’ know-how, the day is…
InSite Vision Announces License Agreement
InSite Vision Incorporated recently announced that it has entered into a license agreement with Nicox S.A., a France-based publicly traded company, for the development and…
ICON to Acquire MediMedia Pharma Solutions
ICON plc recently announced it has agreed, subject to certain customary closing conditions, to acquire MediMedia Pharma Solutions for a cash consideration of $120 million.…
Intercept Receives Breakthrough Therapy Designation
Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), recently announced that its investigational product obeticholic acid (OCA) has received "breakthrough therapy designation" from the US FDA for the…
Global Market for Intravenous Therapy & Vein Access to Reach $27.2 Billion in 2019
BCC Research anticipates that increasing competition, patent expirations, and evolving customer needs will influence research and development (R&D) spending in the intravenous (IV) therapy and…
Continuous Glucose Monitoring Market Surging at 19.6% CAGR; R&D Soon to Create Devices for Faster Administration
BCC Research (www.bccresearch.com) reveals in its new report on continuous glucose monitoring (CGM), the total CGM market is forecast to reach a value of at…
Curis & Aurigene Announce Collaboration, License & Option Agreement
Curis, Inc. and Aurigene Discovery Technologies Limited recently announced they have entered into an exclusive collaboration agreement focused on immuno-oncology and selected precision oncology targets.…
Alnylam Pharmaceuticals Announces $450-Million Proposed Public Offering
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) recently announced it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately…
Pfanstiehl Launches New cGMP-produced, Parenteral-Grade Maltose for Pharmaceutical Formulations
Pfanstiehl recently announced the launch of a new high-purity, low endotoxin, Maltose (USP/NF, EP, JP), manufactured in the US under strict cGMP, ICH Q7- compliant…
Catalent Expands Integrated Softgel Operations
Catalent Pharma Solutions recently announced it will add new coating and blister packaging equipment at its 360,000-sq-ft, Eberbach, Germany, softgel manufacturing facility, expanding the integrated…
Baxter BioPharma Solutions Joins PBOA
The Pharma & Biopharma Outsourcing Association (PBOA) recently announced that Nelson Patterson, Vice President, Sales and Marketing at Baxter BioPharma Solutions, has been elected to…
Innovent Biologics Completes $100-Million Financing to Advance Biologic Pipeline & Operations
Innovent Biologics, Inc. recently announced it has raised $100 million in Series C financing. Legend Capital led the financing. Other new investors included Singapore-based Temasek…
Colorectal Cancer Treatment Market Value to Hit $9.4 Billion
The value of the Colorectal Cancer (CRC) therapeutics market will increase moderately, from $8.3 billion in 2013 to $9.4 billion by 2020, representing a Compound…
Asia-Pacific Continues to Drive Global Healthcare Investment, Innovation & Growth
The dynamic healthcare landscape across the Asia-Pacific is expected to continue its strong growth momentum in areas of new entities, investments and products, with the…
Treatment Market for Irritable Bowel Syndrome Could Hit $1.5 Billion
The global therapeutics market for Irritable Bowel Syndrome (IBS) is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023,…
